Omega Healthcare Investors, Inc. (NYSE:OHI) Director Lisa Egbuonu-Davis Sells 2,500 Shares

Omega Healthcare Investors, Inc. (NYSE:OHI) Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares of the company’s stock, valued at $749,144.64. This trade represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Omega Healthcare Investors Price Performance

OHI stock opened at $40.41 on Thursday. The company has a market capitalization of $11.92 billion, a P/E ratio of 24.94, a price-to-earnings-growth ratio of 2.80 and a beta of 0.66. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. Omega Healthcare Investors, Inc. has a 52-week low of $35.04 and a 52-week high of $44.42. The business has a 50-day simple moving average of $37.89 and a two-hundred day simple moving average of $37.41.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%. The business had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. During the same quarter in the previous year, the business earned $0.71 EPS. The company’s quarterly revenue was up 11.8% on a year-over-year basis. Research analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Monday, August 4th will be paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.6%. The ex-dividend date is Monday, August 4th. Omega Healthcare Investors’s payout ratio is presently 165.43%.

Hedge Funds Weigh In On Omega Healthcare Investors

A number of hedge funds and other institutional investors have recently modified their holdings of OHI. Caitong International Asset Management Co. Ltd purchased a new position in shares of Omega Healthcare Investors in the 2nd quarter worth approximately $26,000. NBC Securities Inc. purchased a new position in shares of Omega Healthcare Investors in the 1st quarter worth approximately $29,000. CENTRAL TRUST Co boosted its stake in shares of Omega Healthcare Investors by 1,654.4% in the 2nd quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust’s stock worth $37,000 after buying an additional 943 shares during the last quarter. Bayforest Capital Ltd boosted its stake in shares of Omega Healthcare Investors by 395.2% in the 2nd quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust’s stock worth $41,000 after buying an additional 901 shares during the last quarter. Finally, Cullen Frost Bankers Inc. purchased a new position in shares of Omega Healthcare Investors in the 2nd quarter worth approximately $41,000. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Royal Bank Of Canada raised their price objective on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a “sector perform” rating in a research note on Thursday, August 7th. Wells Fargo & Company upgraded Omega Healthcare Investors from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $38.00 to $41.00 in a research note on Monday, July 14th. Five analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Omega Healthcare Investors currently has a consensus rating of “Hold” and a consensus target price of $42.00.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.